Diligence memo · auto-generated · as of July 2, 2026
NewLeaf Symbiotics, Inc.
NewLeaf Symbiotics, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
NewLeaf Symbiotics, Inc. operates in Agriculture, based in ST. LOUIS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
NewLeaf Symbiotics, Inc. has raised $137M in disclosed capital across 10 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $47M on 2023-12-12.
Most recent recorded round closed around 2023-12-12.
Valuation (modeled)modeled
Provath models NewLeaf Symbiotics, Inc. at approximately $312M (range $173M–$511M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.51× the median modeled value of Series C Agriculture companies in 2022–2024 (17 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 2.6 yr ago; this sector typically re-raises about every 11 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 7.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 97% of Agriculture peers (1056 compared).
Modeled value ranks above 95% of those peers.
Closest niche peers: RTH Farms, LLP, Open Blue Sea Farms, Inc., VISM Global Agro Invest Corp., Our Family Farm Llc, Jingcaoyuan Holdings Inc.
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.